Fredun Pharmaceuticals consolidated net profit rises 93.94% in the June 2026 quarter

Sales rise 90.75% to Rs 227.76 crore

Net profit of Fredun Pharmaceuticals rose 93.94% to Rs 13.13 crore in the quarter ended June 2026 as against Rs 6.77 crore during the previous quarter ended June 2025. Sales rose 90.75% to Rs 227.76 crore in the quarter ended June 2026 as against Rs 119.40 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	227.76	119.40	91
OPM %	14.37	14.23	-
PBDT	24.12	10.46	131
PBT	20.55	9.04	127
NP	13.13	6.77	94

Powered by Capital Market - Live News